Despite advancements in cancer treatment technologies, most therapies share a common goal: eliminating cancer cells. However, ...

Stenoparib is under clinical development by Allarity Therapeutics and currently in Phase I for Colon Cancer. According to GlobalData, Phase I drugs for Colon Cancer have a 56% phase transition success ...

Using a computational “digital twin” model, researchers mapped the gene networks controlling cell differentiation. They ...

Scientists at KAIST have developed a groundbreaking method to convert colon cancer cells into healthy ones using a ...

KAIST researchers have developed new technology that can transform colon cancer cells into normal-like cells. Led by ...

This is a significant departure from traditional cancer treatments that rely on killing cancer cells, often leading to severe ...

The immune system plays a pivotal role in colorectal cancer (CRC), with immune cells such as T cells, natural killer (NK) cells, macrophages, and dendritic ...

Despite the development of numerous cancer treatment technologies, the common goal of current cancer therapies is to ...

Despite the development of numerous cancer treatment technologies, the common goal of current cancer therapies is to eliminate cancer cells. This approach, however, faces fundamental limitations, ...

A new publication from Genes & Diseases; DOI 10.1016/j.gendis.2024.101441, discusses how Ce6-GFFY is a novel photosensitizer for colorectal cancer therapy.